Total Payments
$131,315
2024 Payments
$1,618
Companies
28
Transactions
447
Medicare Patients
6,853
Medicare Billing
$514,207
Payment Breakdown by Category
Other$103,245 (78.6%)
Food & Beverage$14,410 (11.0%)
Travel$13,335 (10.2%)
Consulting$300.00 (0.2%)
Education$24.99 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $103,245 | 43 | 78.6% |
| Food and Beverage | $14,410 | 359 | 11.0% |
| Travel and Lodging | $13,335 | 40 | 10.2% |
| Consulting Fee | $300.00 | 1 | 0.2% |
| Education | $24.99 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $109,134 | 152 | $0 (2024) |
| Medtronic Vascular, Inc. | $8,271 | 67 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $8,132 | 42 | $0 (2024) |
| Abbott Laboratories | $1,045 | 9 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $790.38 | 59 | $0 (2024) |
| Boston Scientific Corporation | $761.60 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $544.06 | 30 | $0 (2024) |
| BIOTRONIK INC. | $493.72 | 6 | $0 (2024) |
| ShockWave Medical, Inc | $418.21 | 3 | $0 (2024) |
| Philips Electronics North America Corporation | $216.51 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,618 | 49 | E.R. Squibb & Sons, L.L.C. ($256.45) |
| 2023 | $1,736 | 38 | Janssen Pharmaceuticals, Inc ($591.86) |
| 2022 | $17,899 | 45 | Janssen Pharmaceuticals, Inc ($16,411) |
| 2021 | $12,846 | 29 | Janssen Pharmaceuticals, Inc ($8,624) |
| 2020 | $12,231 | 34 | Janssen Pharmaceuticals, Inc ($7,002) |
| 2019 | $28,171 | 67 | Janssen Pharmaceuticals, Inc ($25,067) |
| 2018 | $21,625 | 85 | Janssen Pharmaceuticals, Inc ($18,729) |
| 2017 | $35,189 | 100 | Janssen Pharmaceuticals, Inc ($32,608) |
All Payment Transactions
447 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.65 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $29.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/03/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/26/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/11/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $24.92 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/07/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.76 | General |
| Category: Cardiovascular | ||||||
| 10/18/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/17/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $42.80 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 10/16/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $96.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/14/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/11/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $29.55 | General |
| Category: Genetic Disease | ||||||
| 10/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: DIABETES | ||||||
| 10/03/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $109.96 | General |
| Category: Cardiovascular | ||||||
| 10/03/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.69 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/24/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.51 | General |
| Category: Cardiovascular | ||||||
| 09/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/03/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $19.15 | General |
| 08/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.13 | General |
| Category: Cardiovascular | ||||||
| 08/05/2024 | BIOTRONIK INC. | NHancer Rx (Device), ReCross, Orsiro Mission | Food and Beverage | In-kind items and services | $111.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/05/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Not Applicable | ||||||
| 08/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/29/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $8.50 | General |
| Category: Cardiovascular | ||||||
| 07/09/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $28.06 | General |
| Category: Genetic Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,840 | 2,304 | $433,261 | $125,273 |
| 2022 | 28 | 1,783 | 2,183 | $720,544 | $134,351 |
| 2021 | 18 | 1,623 | 2,000 | $828,278 | $140,476 |
| 2020 | 19 | 1,607 | 1,965 | $661,304 | $114,107 |
Total Patients
6,853
Total Services
8,452
Medicare Billing
$514,207
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 624 | 1,005 | $177,668 | $83,248 | 46.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 44 | 63 | $12,796 | $5,493 | 42.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 101 | 101 | $87,014 | $5,416 | 6.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 38 | 39 | $13,724 | $5,033 | 36.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 509 | 542 | $47,996 | $5,030 | 10.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $12,473 | $4,677 | 37.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 33 | 34 | $8,364 | $4,453 | 53.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 32 | 38 | $6,100 | $2,234 | 36.6% |
| 99451 | Telephone, internet, or electronic health record assessment and management with written report by consulting physician, at least 5 minutes | Office | 2023 | 55 | 62 | $2,480 | $1,660 | 67.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 28 | $3,506 | $1,543 | 44.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 16 | $4,588 | $1,486 | 32.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 20 | 20 | $3,200 | $1,182 | 36.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $2,846 | $984.53 | 34.6% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 91 | 91 | $22,852 | $957.64 | 4.2% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 30 | 30 | $2,160 | $489.90 | 22.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 57 | 70 | $7,056 | $405.60 | 5.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 34 | 36 | $720.00 | $302.40 | 42.0% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 17 | 17 | $12,070 | $226.50 | 1.9% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 11 | 11 | $1,485 | $210.43 | 14.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 29 | 30 | $3,024 | $174.72 | 5.8% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 12 | 12 | $1,140 | $65.40 | 5.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 552 | 851 | $148,550 | $69,980 | 47.1% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2022 | 31 | 39 | $144,374 | $14,980 | 10.4% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2022 | 62 | 62 | $149,730 | $10,741 | 7.2% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2022 | 27 | 27 | $76,410 | $5,911 | 7.7% |
About Dr. Michael Ball, MD
Dr. Michael Ball, MD is a Cardiovascular Disease healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396719761.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Ball, MD has received a total of $131,315 in payments from pharmaceutical and medical device companies, with $1,618 received in 2024. These payments were reported across 447 transactions from 28 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($103,245).
As a Medicare-enrolled provider, Ball has provided services to 6,853 Medicare beneficiaries, totaling 8,452 services with total Medicare billing of $514,207. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Indianapolis, IN
- Active Since 02/14/2006
- Last Updated 05/23/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1396719761
Products in Payments
- XARELTO (Drug) $109,149
- Resolute (Device) $8,227
- BRILINTA (Drug) $8,108
- ELIQUIS (Drug) $565.43
- ENTRESTO (Drug) $387.09
- Orsiro Mission (Device) $357.18
- CAMZYOS (Drug) $334.85
- SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER (Device) $294.29
- WATCHMAN (Device) $292.18
- DIAMONDBACK CORONARY (Device) $194.40
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $181.12
- Repatha (Biological) $177.21
- XIENCE V (Device) $162.23
- LEQVIO (Drug) $156.97
- WATCHMAN Access System (Device) $152.66
- DRAGONFLY OPSTAR (Device) $152.40
- Impella (Device) $147.28
- General - Therapies (Device) $145.54
- Xience Sierra Coronary Stent (Device) $143.80
- ProtekDuo (Device) $142.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Indianapolis
Eric Prystowsky, Md, MD
Cardiovascular Disease — Payments: $1.7M
Cardiovascular Disease $1.7M
Dr. Vijay Rao, M.d., Ph.d, M.D., PH.D
Cardiovascular Disease — Payments: $431,147
Cardiovascular Disease $431,147
James Hermiller, Md, MD
Cardiovascular Disease — Payments: $380,511
Cardiovascular Disease $380,511
Dr. Atul Chugh, M.d, M.D
Cardiovascular Disease — Payments: $213,637
Cardiovascular Disease $213,637
Noel Dasgupta, Md, MD
Cardiovascular Disease — Payments: $164,975
Cardiovascular Disease $164,975
Jeffrey Breall, M.d, M.D
Cardiovascular Disease — Payments: $120,157
Cardiovascular Disease $120,157